Sign in

CIK 0001783183

  • Non-accelerated filer
  • Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
824151574
Phone
+1 877-742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-02-27 Curran Terrie President and Chief Executive Grant or award · Stock Option (Right to Buy) +342,500 342,500
2025-01-21 Curran Terrie President and Chief Executive Sale −19,109 $6.59 $126K 360,465
2024-07-15 Curran Terrie President and Chief Executive Sale −33,848 $11.72 $397K 377,734
2024-03-22 Curran Terrie President and Chief Executive Sale −16,851 $9.11 $154K 410,784
2024-01-18 Curran Terrie President and Chief Executive Grant or award · Stock Option (Right to Buy) +475,000 475,000
2023-11-01 Curran Terrie President and Chief Executive Grant or award +37,500 427,171
2023-07-14 Curran Terrie President and Chief Executive Grant or award +200,000 389,671
2023-07-14 Curran Terrie President and Chief Executive Returned to the company · Stock Option −175,000 0
2023-07-14 Curran Terrie President and Chief Executive Returned to the company · Stock Option −225,000 0
2023-04-06 Curran Terrie President and Chief Executive Purchase +12,919 $7.82 $101K 188,290
2023-03-01 Curran Terrie President and Chief Executive Sale −1,436 $8.54 $12K 175,371
2023-01-20 Curran Terrie President and Chief Executive Sale −5,821 $8.20 $48K 176,807
2023-01-19 Curran Terrie President and Chief Executive Grant or award +97,500 182,628
2023-01-19 Curran Terrie President and Chief Executive Grant or award · Stock Option (Right to Buy) +162,500 162,500
2022-11-21 Curran Terrie President and Chief Executive Sale −1,526 $9.60 $15K 83,720
2022-09-01 Curran Terrie President and Chief Executive Grant or award +7,500 85,246
2022-05-19 Curran Terrie President and Chief Executive Grant or award +12,000 76,595
2022-05-13 Curran Terrie President and Chief Executive Purchase +20,500 $7.41 $152K 64,595
2022-01-19 Curran Terrie President and Chief Executive Grant or award +41,250 44,095
2022-01-19 Curran Terrie President and Chief Executive Grant or award · Stock Option (Right to Buy) +206,250 206,250

Page 1 of 2 · 26 trades